Breast Cancer Trial, Recruiting (NCT06350500)

Breast Cancer Trial, Recruiting NCT06350500 Sponsor: Roswell Park Cancer Institute Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06350500 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 years or older
People who have a confirmed diagnosis of breast cancer or Ductal Carcinoma In Situ (DCIS), which is an early form of breast cancer found in the milk ducts
People who currently identify their gender as a woman or female
People who were assigned female sex at birth
People who are experiencing at least one barrier to getting healthcare, as identified by a social needs screening tool used in the trial
People who understand the research nature of this study and are willing to give verbal consent to take part before any study activities begin

Who may not be able to join:

People who do not have a suspected or confirmed diagnosis of breast cancer or Ductal Carcinoma In Situ (DCIS)
People who have previously been diagnosed with any type of cancer
People who were assigned male sex or intersex sex at birth
People who are unwilling or unable to follow the requirements of the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kathryn Glaser, Roswell Park Comprehensive Cancer Center

Phone: 716-845-7637

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06350500

Sponsor: Roswell Park Cancer Institute

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: 716-845-7637

More information: https://clinicaltrials.gov/study/NCT06350500

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 years or older
People who have a confirmed diagnosis of breast cancer or Ductal Carcinoma In Situ (DCIS), which is an early form of breast cancer found in the milk ducts
People who currently identify their gender as a woman or female
People who were assigned female sex at birth
People who are experiencing at least one barrier to getting healthcare, as identified by a social needs screening tool used in the trial
People who understand the research nature of this study and are willing to give verbal consent to take part before any study activities begin

Who may not be able to join:

People who do not have a suspected or confirmed diagnosis of breast cancer or Ductal Carcinoma In Situ (DCIS)
People who have previously been diagnosed with any type of cancer
People who were assigned male sex or intersex sex at birth
People who are unwilling or unable to follow the requirements of the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Roswell Park Cancer Institute

Registry

ClinicalTrials.gov

Start date

15 December 2024

Est. completion

15 March 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Enrollment rate; Reasons for refusal; Retention Rate; Reasons for discontinuation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov